Loading
ISO 9001:2015 Certified · 62 MT/Month Capacity · 21 Export Markets
Kodel Life manufactures Active Pharmaceutical Ingredients from Morbi, Gujarat, India - supplying cardiovascular, diuretic, and NSAID APIs to pharmaceutical companies across 21 countries. Every batch ships with full COA, DMF, and stability data.
5+
API Products
In commercial production
62
MT/Month Capacity
Peak production capacity
21
Countries Served
Active export markets
5+
Years of Excellence
Industry expertise
Kodel Life specialises in cardiovascular APIs, loop diuretics, and NSAID active pharmaceutical ingredients. All products are manufactured to IP, BP, USP, and EP pharmacopoeial standards, with capacity available for both development-scale and commercial volumes.
C12H11ClN2O5S · CAS 54-31-9
Furosemide is a potent loop diuretic used in the treatment of edema associated with congestive heart failure.
20 MT/ Month
Production Capacity
C7H8ClN3O4S2 · CAS 58-93-5
Thiazide diuretic API for combination cardiovascular therapies.
10 MT/Month
Production Capacity
C34H56N2O10 · CAS 98418-47-4
Extended-release beta-blocker salt for cardiovascular applications.
20 MT/Month
Production Capacity
C34H54N2O12 · CAS 56392-17-7
Immediate-release beta blocker for hypertension, angina, and acute MI.
62 MT/Month
Production Capacity
C15H13N3O4S · CAS 36322-90-4
Non-steroidal anti-inflammatory and analgesic for arthritis and musculoskeletal pain.
62 MT/Month
Production Capacity
Sourcing an API supplier is a regulatory and supply-chain decision, not just a pricing one. Pharmaceutical procurement teams across Asia, Europe, Africa, and the Americas trust Kodel Life because of three things: documented quality, reliable capacity, and complete regulatory support from the first enquiry through to commercial supply.
Every batch produced at the Morbi, Gujarat facility operates under ISO 9001:2015 Quality Management System protocols and FDA-compliant cGMP practices. In-house analytical testing covers identity, purity, assay, impurity profiles, and particle size distribution, with a COA issued per batch.
Active export operations to 21 countries across Southeast Asia, South Asia, the Middle East, Africa, Europe, and the Americas, with a dedicated documentation team handling customs and import compliance for each destination market.
Complete DMF support, stability data packages, and impurity profiles per ICH Q3A guidelines are provided as standard. No chasing documentation after the order ships.
With a peak production capacity of 62 MT per month across the portfolio and dedicated synthesis infrastructure, Kodel Life handles both development batches and long-term commercial supply contracts.
Kodel Life manufactures to IP, BP, USP, and EP standards in a single facility. Buyers receive the pharmacopoeial grade they specify, with COA and reference standard certificates confirming compliance with the applicable monograph.
Located at Survey No. 133/6, Pipaliya, Morbi, Gujarat - one of India's established pharmaceutical manufacturing corridors - the Kodel Life facility is equipped with modern synthesis infrastructure, multi-stage quality checkpoints, and fully documented process controls that meet global GMP expectations.
Kodel Life is expanding its API portfolio to serve additional therapeutic categories. Three products are currently in development, with commercial supply expected as each completes process validation and regulatory documentation.
Sulfonylurea antidiabetic agent for Type 2 diabetes management
Broad-spectrum fluoroquinolone antibiotic for bacterial infections
DPP-4 inhibitor for Type 2 diabetes glycaemic control
Kodel Life APIs are used in pharmaceutical manufacturing operations across Southeast Asia, South Asia, the Middle East, East Africa, Europe, and North and South America. Export documentation, customs support, and regulatory dossiers are handled in-house for each destination market.
Buyers in regulated markets (EU, US, Canada) receive open or closed DMF reference letters and eCTD-compatible documentation packages. Buyers in emerging markets receive COA, stability data, and local import compliance support.
Every API batch undergoes a defined quality protocol from raw material receipt through to final release. The system is built to satisfy drug authority requirements across all 21 export markets, from CDSCO in India to USFDA, EMA, and national regulators across Asia and Africa.
View Our Certifications →Organization for Standardization
Quality Management System certified
Food & Drug Administration
Manufacturing processes compliant with FDA regulations
furosemide api
Complete buyer's guide to sourcing pharmaceutical-grade Furosemide API for Saudi Arabia: SFDA plant registration, WHO-GMP requirements, King Abdullah Port import, and supplier evaluation.
Piroxicam API
Deep dive into Piroxicam API manufacturing: synthesis route from saccharin, cGMP controls, polymorph formation, ICH Q3A impurity qualification, and process transparency for B2B buyers.
furosemide api
A practical guide to sourcing Furosemide API wholesale in Canada, covering supplier evaluation, Health Canada compliance, GMP requirements, quality documentation, import considerations, bulk pricing factors, and key checks Canadian pharmaceutical buyers should complete before selecting a reliable API supplier.
Kodel Life manufactures five commercial APIs: Furosemide (loop diuretic), Metoprolol Succinate (beta blocker, ER), Metoprolol Tartrate (beta blocker, IR), Piroxicam (NSAID), and Hydrochlorothiazide (thiazide diuretic). The company also supplies pharmaceutical intermediates including Metoprolol Epoxide, Metoprolol Base, and Sodium Furosemide.
Peak production capacity across the portfolio is 62 MT per month. Individual API capacities are: Furosemide 20 MT/month, Metoprolol Succinate 20 MT/month, Metoprolol Tartrate 62 MT/month, Piroxicam 62 MT/month, and Hydrochlorothiazide 10 MT/month. Contact the team to confirm availability for your specific volume requirement.
Yes. The Morbi, Gujarat facility is ISO 9001:2015 certified and operates under FDA-compliant cGMP manufacturing practices. COA, DMF, and full regulatory documentation are available for all commercial APIs.
Kodel Life exports to 21 countries across 5 continents: Thailand, Vietnam, Myanmar, Malaysia, Philippines (Southeast Asia); Sri Lanka, Bangladesh, Nepal, Pakistan (South Asia); UAE, Saudi Arabia, Jordan (Middle East); Kenya, Tanzania, Nigeria, Ethiopia, South Africa (Africa); Germany, Russia, Ukraine (Europe); USA, Brazil, Canada (Americas).
Standard documentation includes a batch-specific Certificate of Analysis (COA) to the specified pharmacopoeial standard (IP/BP/USP/EP), Drug Master File (DMF) or reference letter support, stability data per ICH Q1A, impurity profiles per ICH Q3A, and method validation certificates. Additional documentation for specific regulatory authorities is available on request.
Use the "Request a Sample" or "Request COA & DMF" button on any product page, or contact the team via the enquiry form or WhatsApp (+91 75023 33335). The team responds within 1–2 business days with specifications, availability, and next steps.
Kodel Life is located at Survey No. 133/6, Pipaliya, Morbi, Gujarat 363660, India. The current API portfolio covers cardiovascular therapy (beta blockers), diuretics (loop and thiazide), and anti-inflammatory/analgesic (NSAID) therapeutic areas.
Kodel Life works with pharmaceutical manufacturers, generic drug companies, CDMOs, and trading houses sourcing cardiovascular, diuretic, and NSAID APIs from India. Whether you need a development sample, a regulatory documentation package, or commercial supply at volume - the team responds within 1-2 business days.